OncoMethylome Becomes MDxHealth, Sharpens Focus on Molecular Dx for Cancer

MDxHealth aims to leverage its DNA methylation platform to develop and commercialize molecular diagnostic, prognostic, and predictive tests for cancer patients.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories